1.
Int Forum Allergy Rhinol
; 14(8): 1399-1401, 2024 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38409897
RESUMO
KEY POINTS: This study examines the impact of dupilumab on medication use for chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma patients. Patients on dupilumab had a reduction in oral/inhaled/topical steroids, antibiotics, and leukotriene receptor antagonists (LTRAs). The reduction in medication use had no impact on total polyp or SNOT-22 scores.